NEW YORK — Pfizer's acquisition of Wyeth may shake up the pharmaceutical industry, but executives contacted by SN said it would have little impact on supermarket pharmacy. The definitive merger was reported last week. Pfizer, here, will buy Wyeth, Madison, N.J., in a cash-and-stock transaction valued at $50.19 per share, or a total of about $68 billion. Some 8,000 jobs are expected to be eliminated. Pfizer is the nation's leading pharmaceutical manufacturer, but Wyeth is stronger in ...

REGISTER TO VIEW THIS ARTICLE - Register for a Free Account

WhyRegisterfor FREE?

Registering for content on Supermarket News will give youINSTANTaccess to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’sFREE, easy and quick. What are you waiting for!In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.

Click here to read the FAQ page if you have any questions (opens in a new window)

Attention Paid Print Subscribers: While you have already been grantedfreeaccess to SNwe ask that youregister now.We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.

Already registered? here.